Extended interval dosing of natalizumab: a two-center, 7-year experience
about
Extended interval dosing of natalizumab in multiple sclerosis.New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing.Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients.Body weight-based natalizumab treatment in adult patients with multiple sclerosis.Monitoring CD49d receptor occupancy: A method to optimize and personalize natalizumab therapy in multiple sclerosis patients.
P2860
Q31049360-885B22B2-9CAC-450A-A355-6E77BF6AB8BAQ37045253-75F5C493-AA74-4299-85A1-41437794967FQ38796218-0EB6F2FC-5429-4A40-BDE4-3E3E3156FFDAQ41168849-7CCDAF63-76DE-44FD-A02B-7633ADB716ACQ42350202-22846CEA-C642-487E-B7C2-DAD9ECA7B123Q47406798-EC08F067-54AA-48F6-A85D-47C7DB134109Q48669278-EAC2214A-2E02-458B-958A-482E4B6ECF00
P2860
Extended interval dosing of natalizumab: a two-center, 7-year experience
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Extended interval dosing of natalizumab: a two-center, 7-year experience
@ast
Extended interval dosing of natalizumab: a two-center, 7-year experience
@en
Extended interval dosing of natalizumab: a two-center, 7-year experience
@nl
type
label
Extended interval dosing of natalizumab: a two-center, 7-year experience
@ast
Extended interval dosing of natalizumab: a two-center, 7-year experience
@en
Extended interval dosing of natalizumab: a two-center, 7-year experience
@nl
prefLabel
Extended interval dosing of natalizumab: a two-center, 7-year experience
@ast
Extended interval dosing of natalizumab: a two-center, 7-year experience
@en
Extended interval dosing of natalizumab: a two-center, 7-year experience
@nl
P2860
P356
P1476
Extended interval dosing of natalizumab: a two-center, 7-year experience
@en
P2093
Roberto Bomprezzi
Siddharama Pawate
P2860
P304
P356
10.1177/1756285614540224
P577
2014-09-01T00:00:00Z